Semaglutide

Compare clinics and online programs offering semaglutide for medically supervised weight management. Verified providers, transparent pricing, US & UK. This page is informational and does not diagnose, prescribe, or recommend therapies.

Looking for clinics by city? Explore peptide clinics in Miami , Los Angeles, and New York to compare verified providers by treatment focus.

Recovery peptide users often compare BPC-157 and TB-500, while metabolic health users usually cross-reference semaglutide.

If you are actively evaluating treatment access, you can compare semaglutide providers, get matched with a provider, or find a peptide clinic near you.

Common contexts

  • Frequently referenced in clinician-led weight management and metabolic health programmes.
  • Many clinics pair semaglutide with nutritional support, baseline screening, and follow-up monitoring.
  • It is one of the most established peptide-adjacent topics in the directory by evidence depth and prescribing structure.

Safety information

  • Semaglutide is a prescription medicine and should only be accessed through licensed clinician supervision.
  • Ask how side effects, dose escalation, contraindications, and ongoing review are handled.
  • Clinic quality varies, so look for transparent prescriber credentials and monitoring protocols.

Quick summary

  • Semaglutide is a prescription GLP-1 medicine usually researched through weight-management and metabolic-health clinics.
  • Clinics can package semaglutide very differently, from low-friction telehealth access to physician-led programmes with monitoring.
  • The most useful comparison points are prescriber oversight, side-effect support, dose-escalation structure, and total monthly cost.
  • Semaglutide is commonly cross-referenced with tirzepatide when users are comparing programme intensity and expected follow-up.
  • City context matters because clinics in Los Angeles, New York, and Miami often position semaglutide differently.
  • This page is informational only and should be used to compare provider positioning, not to self-diagnose or self-prescribe.

Evidence at a glance

A scannable summary of what the current research and UK/US regulatory position actually show. Educational only — not medical advice, and no dosing guidance.

Evidence
Among the strongest evidence bases of any treatment in this directory: large Phase 3 programmes (STEP trials — ~14.9% average weight loss at 68 weeks on the 2.4 mg weight-management dose vs ~2.4% placebo) plus a dedicated cardiovascular outcomes trial (SELECT) that led to an added CV risk-reduction indication.
Human data
Extensive — tens of thousands of trial participants across diabetes, weight-management, and outcomes studies, plus years of real-world prescribing data.
UK regulatory status
Licensed, prescription-only medicine in the UK across specific products and indications for type 2 diabetes and weight management, including an oral weight-management form approved by the MHRA in June 2026. Unlicensed online sales and counterfeit pens are an active MHRA enforcement area.
US regulatory status
FDA-approved across several products for type 2 diabetes and chronic weight management, with additional cardiovascular and kidney-related indications on particular products. Compounded copies are heavily restricted since the FDA declared the shortage resolved in February 2025.
Anti-doping (sport)
GLP-1 medicines are not currently named on the WADA prohibited list; tested athletes should verify against the current list as it changes annually.

Last reviewed 14 August 2026. Regulatory status can change — always confirm the current position with a qualified clinician.

Claim vs evidence

Common marketing and internet claims about Semaglutide, set against what the research actually shows. Educational only — not medical advice.

ClaimHuman evidenceWhat the evidence shows
Compounded semaglutide is the same as the licensed medicineNot equivalentThe trial evidence belongs to the licensed, regulator-inspected products. Compounded copies are not FDA-approved, are heavily restricted since the shortage was declared resolved in February 2025, and their quality control is not comparable by definition.
'Natural semaglutide alternatives' give similar resultsNo supplement comes closeNo supplement or 'natural GLP-1 booster' has trial evidence approaching the licensed medicine's ~15% average weight loss. Marketing that borrows semaglutide's numbers for other products is borrowing evidence it does not have.
Microdosing semaglutide gets the benefits without side effectsUntestedThe trial results come from studied dose-escalation protocols. 'Microdosing' regimens promoted online have no trial evidence for efficacy or safety at those doses — they are improvisation on top of a proven medicine.

Clear intro

Semaglutide attracts high-intent users who are already comparing prescribing models, monthly pricing, and side-effect support. The strongest clinics explain how they assess suitability, not just how fast they can start treatment.

Who this is for

This page is most useful for patients comparing clinician-led weight-management pathways, metabolic support, and city-level clinic options in markets such as Miami, Los Angeles, and New York.

What to ask before choosing a clinic

  • Who is prescribing and reviewing progress?
  • How are side effects and dose changes handled?
  • What does the monthly fee include beyond medication access?

Pricing and red flags

Semaglutide programmes can range from lower-touch access models to more structured physician-led packages with repeat review, nutrition support, and diagnostics.

  • Assessment-free access language.
  • No clear explanation of contraindications or side effects.
  • Unclear pricing that hides review or medication costs.

What is Semaglutide?

Semaglutide is a GLP-1 receptor agonist used in mainstream medical care for blood sugar regulation and chronic weight-management pathways. In plain English, it is a prescription treatment that helps regulate appetite and metabolic signaling, so it usually appears on clinic pages focused on obesity medicine, medically supervised weight loss, and metabolic-health support.

How it works

At a high level, semaglutide mimics a gut hormone involved in appetite and glucose regulation. Clinics often explain that this can affect fullness, eating patterns, and blood sugar handling, but the practical patient experience depends more on dose escalation, side-effect management, and the broader care model than on mechanism language alone.

Typical use cases

  • Clinician-led weight-management programmes for people comparing medical support rather than general wellness plans.
  • Metabolic-health pathways where clinics also discuss insulin resistance, blood sugar review, and longer-term obesity management.
  • Longevity or preventative-health settings where weight and cardiometabolic risk are part of a wider care plan.

Cost overview

Semaglutide pricing commonly falls in a broad monthly band, often around the same range covered in the broader cost guide. The more meaningful question is whether that fee includes clinician review, messaging access, follow-up, and medication supply. Compare this with the dedicated cost breakdown in the peptide therapy cost guide before shortlisting a clinic. See the peptide therapy cost guide.

What to expect from clinics

  • A proper consultation should cover health history, current medications, and whether semaglutide fits your goal and risk profile.
  • Programmes vary widely: some include regular review and lifestyle support, while others are closer to prescribing access only.
  • Pricing can look similar at first glance while including very different levels of medical input and follow-up.

Frequently asked questions about Semaglutide

Is semaglutide licensed in the UK?

Yes. Semaglutide is a licensed, prescription-only medicine in the UK, but licensing attaches to specific products and indications rather than to the substance in general — some licensed products are authorised for weight management, others for type 2 diabetes. In June 2026 the MHRA also approved an oral (tablet) form for weight management, the first weight-loss tablet licensed in the UK; a separate, longer-standing tablet product remains licensed for type 2 diabetes only and is not interchangeable with it. Whether any of these is appropriate for a given person is a decision for a qualified prescriber.

Is semaglutide approved in the US?

Yes. In the US, semaglutide is FDA-approved across several products — for chronic weight management and for type 2 diabetes — with additional cardiovascular and, from 2025, chronic-kidney-disease risk indications attached to particular products. As in the UK, approval is tied to a specific product and its licensed indication, not to the molecule in the abstract.

Is compounded semaglutide legal?

It is far more restricted than it was. The FDA declared the semaglutide shortage resolved in February 2025, which closed the window in which pharmacies could routinely compound copies of the licensed products. Patient-specific compounding by a 503A pharmacy where a documented clinical need exists, and limited 503B outsourcing-facility supply, remain the narrow exceptions — and in April 2026 the FDA proposed excluding semaglutide from the 503B bulk drug substances list, which would restrict large-scale compounding further. If a provider offers a compounded version, ask them to explain the legal basis and the compounding pharmacy's licensing.

Can I buy semaglutide without a prescription?

No. Semaglutide is prescription-only in both the UK and the US, and obtaining it outside a regulated prescribing route is unlawful as well as unsafe. UK regulators have shut down illicit manufacturing of unlicensed weight-loss injection pens and made substantial seizures, and independent testing of counterfeit products has found active ingredient at concentrations far outside anything present in a licensed medicine. Any legitimate provider will require a proper medical assessment first.

What should I ask a clinic offering semaglutide?

Ask who the prescribing clinician is and where they are registered; how suitability, contraindications and existing medications are assessed; how side effects and treatment review are handled; what the monthly fee actually includes beyond access to medication; and what happens if the treatment is not tolerated or is not working. A provider who cannot answer those plainly is not one to shortlist.

Is semaglutide the same as tirzepatide?

No. They are different medicines acting on different hormonal pathways, though they are often compared in weight-management and metabolic care. Which of them — if either — is clinically appropriate is a prescriber's judgement, based on medical history and what is licensed for that person's situation. This directory is informational and does not diagnose, prescribe, or recommend treatments.

Related comparisons: Cagrilintide (CagriSema) vs Semaglutide, Semaglutide vs Tirzepatide, Semaglutide vs Sermorelin, Semaglutide vs Liraglutide.

Next step

Compare Providers and Next Steps

If you are considering this treatment, compare providers, review your options, and choose the path that best fits your goals and preferred level of care.

Related Semaglutide pages

Move from peptide research into clinic comparisons, guides, and matching.

Not sure whether local clinics or online options are the better fit? compare providers or use our matching tool to find the right next step. You can also semaglutide weight loss guide before shortlisting clinics. If you want a broader market view first, find a peptide clinic near you.

Clinics offering Semaglutide

LiveNow Longevity logo
RecommendedVerified

LiveNow Longevity

Las Vegas, NV, USA

LiveNow Longevity is a physician-led longevity and peptide clinic in Las Vegas — built on a simple promise: transparent medicine with no markup on your meds. Founded by board-certified neurologist Dr. Charles Kamen, MD, every patient starts with an $88 medical evaluation including baseline labs. From there, care can include peptide therapy, anti-aging treatments, GLP-1 weight loss (semaglutide and tirzepatide), NAD+ therapy, hormone optimization, and recovery support. In person in Las Vegas, or via telehealth across Nevada.

  • Doctor-led
Physician-led by Dr. Charles Kamen, MD
View Profile
Menon Health logo
FeaturedVerified

Menon Health

London, United Kingdom

Menon Health is a Mayfair-based peptide therapy clinic founded by Dr Mukil Menon, a GMC-registered physician and one of the first doctors to prescribe medical peptide therapy in the UK. Before establishing Menon Health, Dr Menon served as UK medical director at Koniver Wellness, launching the clinic at Soho House London. He continues to practise within the NHS alongside his private consultations, ensuring his protocols stay grounded in current medical standards. The clinic offers doctor-led, prescription-based peptide therapy alongside regenerative cell complex treatments, bloods and diagnostics, and IV therapy. All formulations are sourced from GMP-certified, EMA-regulated pharmacies and dispensed as pre-filled pens, vials, or multi-peptide syringes — Menon Health's approach to combining multiple peptides in a single dose is designed to improve precision and patient adherence. Based at 64 North Row in Mayfair, London, Menon Health serves patients across the UK, Europe, Canada, and the United States, with consultations available in person or remotely.

  • Google 3.7 (3)
GMC-registered physicians

From £195

View Profile
Medical Express Clinic logo

Medical Express Clinic

London, United Kingdom

Based in London, UK, Medical Express Clinic is a medical weight loss clinic. Its listed focus spans weight management. It holds a 4.2-star Google rating from 237 reviews.

  • Google 4.2 (237)
View Profile
The Virtual Slimming Clinic logo

The Virtual Slimming Clinic

London, United Kingdom

The Virtual Slimming Clinic is a medical weight loss clinic in London, UK. The clinic is associated with weight management. It holds a 3.9-star Google rating from 9 reviews.

  • Google 3.9 (9)
View Profile

Explore clinics by city

What to do next

Move from treatment research into provider comparison by choosing the next step that fits your buying journey. Some users want to compare programmes first, while others want a faster route into matched options or local clinic discovery.

If you want more context before comparing clinics, read the semaglutide weight loss guide.

Next step

Explore suitable clinics

Move from peptide research into real provider comparison by checking city pages, cost context, and related treatment comparisons. Clinics vary more by oversight and programme structure than by peptide name alone.

Map preview
Mapbox map preview

For clinics

Are you a clinic?

Get featured on this page and reach patients actively looking for peptide therapy, GLP-1 treatments, recovery support, and longevity care.